HUP0104838A3 - 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders, process for their preparation and intermediates - Google Patents
4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders, process for their preparation and intermediatesInfo
- Publication number
- HUP0104838A3 HUP0104838A3 HU0104838A HUP0104838A HUP0104838A3 HU P0104838 A3 HUP0104838 A3 HU P0104838A3 HU 0104838 A HU0104838 A HU 0104838A HU P0104838 A HUP0104838 A HU P0104838A HU P0104838 A3 HUP0104838 A3 HU P0104838A3
- Authority
- HU
- Hungary
- Prior art keywords
- aminomethyl
- intermediates
- preparation
- gastrointestinal disorders
- treating gastrointestinal
- Prior art date
Links
- 208000018522 Gastrointestinal disease Diseases 0.000 title 1
- SZVHQUMEPYZZTA-UHFFFAOYSA-N benzamide;piperidin-4-ylmethanamine Chemical class NCC1CCNCC1.NC(=O)C1=CC=CC=C1 SZVHQUMEPYZZTA-UHFFFAOYSA-N 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98204411 | 1998-12-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0104838A2 HUP0104838A2 (hu) | 2002-07-29 |
HUP0104838A3 true HUP0104838A3 (en) | 2003-05-28 |
Family
ID=8234539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0104838A HUP0104838A3 (en) | 1998-12-22 | 1999-12-14 | 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders, process for their preparation and intermediates |
Country Status (34)
Country | Link |
---|---|
US (2) | US6544997B1 (hu) |
EP (1) | EP1140915B1 (hu) |
JP (1) | JP4615725B2 (hu) |
KR (1) | KR100633680B1 (hu) |
CN (1) | CN1150190C (hu) |
AR (1) | AR024240A1 (hu) |
AT (1) | ATE297917T1 (hu) |
AU (1) | AU770397B2 (hu) |
BG (1) | BG64953B1 (hu) |
BR (1) | BR9916491A (hu) |
CA (1) | CA2355857C (hu) |
CZ (1) | CZ300851B6 (hu) |
DE (1) | DE69925865T2 (hu) |
DK (1) | DK1140915T3 (hu) |
EA (1) | EA003608B1 (hu) |
EE (1) | EE200100335A (hu) |
ES (1) | ES2245131T3 (hu) |
HK (1) | HK1039114B (hu) |
HR (1) | HRP20010445A2 (hu) |
HU (1) | HUP0104838A3 (hu) |
ID (1) | ID28953A (hu) |
IL (1) | IL143858A (hu) |
MY (1) | MY121852A (hu) |
NO (1) | NO321324B1 (hu) |
NZ (1) | NZ512871A (hu) |
PL (1) | PL197409B1 (hu) |
PT (1) | PT1140915E (hu) |
SI (1) | SI1140915T1 (hu) |
SK (1) | SK285829B6 (hu) |
TR (1) | TR200101962T2 (hu) |
TW (1) | TW570920B (hu) |
UA (1) | UA71591C2 (hu) |
WO (1) | WO2000037461A1 (hu) |
ZA (1) | ZA200105135B (hu) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100370983C (zh) * | 2002-09-12 | 2008-02-27 | 长濑化成株式会社 | 药物组合物 |
AU2004254191B2 (en) * | 2003-06-19 | 2010-03-11 | Janssen Pharmaceutica N.V. | Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists |
EA009259B1 (ru) * | 2003-06-19 | 2007-12-28 | Янссен Фармацевтика Н.В. | Аминосульфонилзамещенные 4-(аминометил)пиперидинбензамиды в качестве 5ht-антагонистов |
EA008514B1 (ru) * | 2003-06-19 | 2007-06-29 | Янссен Фармацевтика Н.В. | Гетероциклические замещенные 4-(аминометил)пиперидин бензамиды в качестве 5-нт-антагонистов |
WO2005003122A1 (en) * | 2003-06-19 | 2005-01-13 | Janssen Pharmaceutica N.V. | 5ht4-antagonistic 4-(aminomethyl)-piperidine benzamides |
JO2478B1 (en) * | 2003-06-19 | 2009-01-20 | جانسين فارماسوتيكا ان. في. | (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists |
GEP20084527B (en) * | 2003-09-03 | 2008-11-10 | Pfizer | Benzimidazolone compounds having 5-ht4 receptor agonistic activity |
DK1689742T3 (da) * | 2003-11-24 | 2010-05-17 | Pfizer | Quinoloncarboxylsyreforbindelser med 5-HT-receptor-agonistisk aktivitet |
TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
TWI351282B (en) | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
MXPA06014486A (es) | 2004-06-15 | 2007-03-01 | Pfizer | Derivados de acido carboxilico de bencimidazolona. |
US20060035890A1 (en) * | 2004-08-10 | 2006-02-16 | Amit Banerjee | Compounds and methods for the treatment of ubiquitin conjugating disorders |
EP1807422B1 (en) * | 2004-11-05 | 2009-09-02 | Theravance, Inc. | 5-ht4 receptor agonist compounds |
US7396933B2 (en) * | 2004-11-05 | 2008-07-08 | Theravance, Inc. | Quinolinone-carboxamide compounds |
ATE469897T1 (de) * | 2004-12-22 | 2010-06-15 | Theravance Inc | Indazolcarbonsäureamidverbindungen |
BRPI0608392A2 (pt) * | 2005-03-02 | 2009-12-29 | Theravance Inc | compostos de quinolinona como agonistas do receptor 5-ht4 |
US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
US8377968B2 (en) | 2008-06-02 | 2013-02-19 | Zalicus Pharmaceuticals, Ltd. | N-piperidinyl acetamide derivatives as calcium channel blockers |
US10208023B2 (en) | 2013-03-01 | 2019-02-19 | Mark G. DeGiacomo | Heterocyclic inhibitors of the sodium channel |
WO2017066705A1 (en) * | 2015-10-14 | 2017-04-20 | Aquinnah Pharmaceuticals, Inc. | Compounds, compositions and methods of use against stress granules |
CN114340670A (zh) | 2019-07-11 | 2022-04-12 | 普拉克西斯精密药物股份有限公司 | T-型钙通道调节剂的制剂及其使用方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ225152A (en) * | 1987-07-17 | 1990-04-26 | Janssen Pharmaceutica Nv | Heterocyclically substituted piperidinyl benzamides as pharmaceuticals |
CA1317940C (en) * | 1987-09-25 | 1993-05-18 | Georges H. P. Van Daele | Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
US5374637A (en) * | 1989-03-22 | 1994-12-20 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
NZ243993A (en) | 1991-08-20 | 1994-10-26 | Smithkline Beecham Plc | Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity |
ATE182591T1 (de) * | 1991-09-12 | 1999-08-15 | Smithkline Beecham Plc | 5-ht4 rezeptor antagonisten |
ES2121988T3 (es) * | 1992-01-23 | 1998-12-16 | Toray Industries | Derivado de morfinano y uso medicinal. |
NZ246915A (en) * | 1992-02-06 | 1996-05-28 | Smithkline Beecham Plc | Benzopyran, benzothiopyran and benzofuran derivatives, preparation and pharmaceutical compositions thereof |
US5708174A (en) | 1992-03-12 | 1998-01-13 | Smithkline Beecham P.L.C. | Heterocyclic-esters or -amides used as 5-HT4 receptor antagonists |
GB9219163D0 (en) | 1992-09-10 | 1992-10-28 | Smithkline Beecham Plc | Pharmaceuticals |
MX9306311A (es) | 1992-10-13 | 1994-04-29 | Smithkline Beecham Plc | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen |
AU680453B2 (en) | 1992-11-05 | 1997-07-31 | Smithkline Beecham Plc | Piperidine derivatives as 5-HT4 receptor antagonists |
GB9301660D0 (en) * | 1993-01-28 | 1993-03-17 | Smithkline Beecham Plc | Pharmaceuticals |
GB9312348D0 (en) | 1993-06-16 | 1993-07-28 | Smithkline Beecham Plc | Pharmaceuticals |
ES2103675B1 (es) * | 1995-01-10 | 1998-07-01 | Almirall Lab | Nuevas piperidinas sustituidas. |
IT1275903B1 (it) | 1995-03-14 | 1997-10-24 | Boehringer Ingelheim Italia | Esteri e ammidi della 1,4-piperidina disostituita |
GB9507882D0 (en) * | 1995-04-18 | 1995-05-31 | Pharmacia Spa | Substituted dihydrobenzofuran derivatives as 5-ht4 agonists |
JP2000516198A (ja) * | 1996-02-15 | 2000-12-05 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | セロトニンの再取り込み阻害剤の胃腸に対する作用を克服するための5ht4レセプター拮抗剤の使用 |
TW445263B (en) * | 1996-02-29 | 2001-07-11 | Janssen Pharmaceutica Nv | Novel esters of 1,4-disubstituted piperidine derivatives |
TW548103B (en) * | 1997-07-11 | 2003-08-21 | Janssen Pharmaceutica Nv | Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
CA2340952C (en) * | 1998-09-10 | 2009-12-08 | F. Hoffmann-La Roche Ag | Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists |
DE10217868A1 (de) * | 2002-04-22 | 2003-10-30 | Jomed N V | Ballon-Katheter |
-
1999
- 1999-12-03 TW TW088121125A patent/TW570920B/zh not_active IP Right Cessation
- 1999-12-14 CA CA002355857A patent/CA2355857C/en not_active Expired - Fee Related
- 1999-12-14 EP EP99967956A patent/EP1140915B1/en not_active Expired - Lifetime
- 1999-12-14 HU HU0104838A patent/HUP0104838A3/hu unknown
- 1999-12-14 DE DE69925865T patent/DE69925865T2/de not_active Expired - Lifetime
- 1999-12-14 PT PT99967956T patent/PT1140915E/pt unknown
- 1999-12-14 UA UA2001064399A patent/UA71591C2/uk unknown
- 1999-12-14 CZ CZ20012117A patent/CZ300851B6/cs not_active IP Right Cessation
- 1999-12-14 CN CNB998147699A patent/CN1150190C/zh not_active Expired - Fee Related
- 1999-12-14 EA EA200100710A patent/EA003608B1/ru not_active IP Right Cessation
- 1999-12-14 WO PCT/EP1999/010064 patent/WO2000037461A1/en active IP Right Grant
- 1999-12-14 DK DK99967956T patent/DK1140915T3/da active
- 1999-12-14 IL IL14385899A patent/IL143858A/xx not_active IP Right Cessation
- 1999-12-14 SK SK859-2001A patent/SK285829B6/sk not_active IP Right Cessation
- 1999-12-14 NZ NZ512871A patent/NZ512871A/xx unknown
- 1999-12-14 EE EEP200100335A patent/EE200100335A/xx unknown
- 1999-12-14 BR BR9916491-4A patent/BR9916491A/pt not_active Application Discontinuation
- 1999-12-14 TR TR2001/01962T patent/TR200101962T2/xx unknown
- 1999-12-14 AU AU24328/00A patent/AU770397B2/en not_active Ceased
- 1999-12-14 US US09/857,905 patent/US6544997B1/en not_active Expired - Lifetime
- 1999-12-14 JP JP2000589532A patent/JP4615725B2/ja not_active Expired - Fee Related
- 1999-12-14 ES ES99967956T patent/ES2245131T3/es not_active Expired - Lifetime
- 1999-12-14 PL PL348417A patent/PL197409B1/pl unknown
- 1999-12-14 SI SI9930822T patent/SI1140915T1/sl unknown
- 1999-12-14 ID IDW00200101336A patent/ID28953A/id unknown
- 1999-12-14 KR KR1020017005055A patent/KR100633680B1/ko not_active IP Right Cessation
- 1999-12-14 AT AT99967956T patent/ATE297917T1/de not_active IP Right Cessation
- 1999-12-17 MY MYPI99005534A patent/MY121852A/en unknown
- 1999-12-21 AR ARP990106644A patent/AR024240A1/es active IP Right Grant
-
2001
- 2001-06-07 BG BG105571A patent/BG64953B1/bg unknown
- 2001-06-08 NO NO20012858A patent/NO321324B1/no not_active IP Right Cessation
- 2001-06-14 HR HR20010445A patent/HRP20010445A2/hr not_active Application Discontinuation
- 2001-06-21 ZA ZA200105135A patent/ZA200105135B/en unknown
-
2002
- 2002-01-29 HK HK02100161.1A patent/HK1039114B/zh not_active IP Right Cessation
-
2003
- 2003-01-29 US US10/353,307 patent/US7205410B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0104838A3 (en) | 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders, process for their preparation and intermediates | |
AU2001238472A1 (en) | Method for treating parathyroid disorders | |
ZA985488B (en) | Novel process for manufacturing paroxetine solid dispersions | |
EP1419218A4 (en) | METHOD FOR CONTINUOUS TREATMENT OF NAPHTHA | |
HK1075839A1 (en) | Crystalline 2,5-dione-3-(1-methyl-1h-indol-3yl)-4-1-(pyridin-2-ylmethyl)piperidin-4-yl-1h-pyrrole mono-hydrochloride | |
HK1041880A1 (en) | Compounds and methods for treatment of asthma, allergy and inflammatory disorders. | |
MXPA03006607A (es) | Metodo combinado para tratar trastornos dependientes de hormonas. | |
HUP0200778A3 (en) | Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments and their intermediates | |
EP1474535A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AIDS AND HIV RELATED DISORDERS USING MOLECULES 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324 , 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045. | |
WO2000053182A3 (en) | 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis | |
ZA200203435B (en) | Method and compositions for treating pulmonary diseases. | |
HUP9902530A3 (en) | New process for producing 4-(1-hydroxyl-1-methyl-ethyl)-furane-2-sulfonamide, and intermediates | |
SG77692A1 (en) | Process and intermediates for the manufacture of pyridine-2, 3-dicarboxylate compounds | |
MXPA03006723A (es) | Metodo para prevenir y tratar dolor visceral y trastornos gastrointestinales. | |
IL157929A0 (en) | Method of producing n-substituted 2,6-dialkyl morpholines | |
AU2002310949A1 (en) | Method of producing N-substituted 2,6-dialkyl morpholines | |
HUP0201400A3 (en) | Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones and their new intermediates | |
IL154202A0 (en) | Pharmaceutical compositions for treating anorectal disorders | |
HUP0301515A3 (en) | Process for the preparation of chiral 1,4-diaryl-2-fluoro-2-butenes and their intermediates | |
AU2002361711A8 (en) | Methods and compositions for treating hematological disorders using 252, 304, 19870, 14717, 9941, 19310 and 17832 | |
IL128397A0 (en) | Improved method for the preparation of 3,5-dichloro-2,4,6-trifluoropyridine | |
HK1031881A1 (en) | Process for preparing 8-cyclopentyl-6-ethyl-3-Äsu bstitutedÜ-5,8-dihydro-4H-1,2,3A, 7,8-pentaaza-as-indacenes and intermediates useful therein. | |
EP1451364A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEMATOLOGICAL DISORDERS USING GENES 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 OR 58874 | |
AU2002229796A1 (en) | Method for treating sleep disorders | |
PL348441A1 (en) | Method of manufacture of 2,2,6,6-tetramethylpiperidine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |